A novel tumor-targeted delivery system with hydrophobized hyaluronic acid–spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery

MLA

Shen, Yan, et al. “A Novel Tumor-Targeted Delivery System with Hydrophobized Hyaluronic Acid–spermine Conjugates (HHSCs) for Efficient Receptor-Mediated SiRNA Delivery.” International Journal of Pharmaceutics, vol. 414, no. 1/2, July 2011, pp. 233–43. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2011.04.049.

APA

Shen, Y., Wang, B., Lu, Y., Ouahab, A., Li, Q., & Tu, J. (2011). A novel tumor-targeted delivery system with hydrophobized hyaluronic acid–spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. International Journal of Pharmaceutics, 414(1/2), 233–243. https://doi.org/10.1016/j.ijpharm.2011.04.049

Chicago

Shen, Yan, Buhai Wang, Yang Lu, Ammar Ouahab, Qian Li, and Jiasheng Tu. 2011. “A Novel Tumor-Targeted Delivery System with Hydrophobized Hyaluronic Acid–spermine Conjugates (HHSCs) for Efficient Receptor-Mediated SiRNA Delivery.” International Journal of Pharmaceutics 414 (1/2): 233–43. doi:10.1016/j.ijpharm.2011.04.049.